A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing

Acta Orthopaedica

Volumn 80, Issue 5, 2009, Pages 597-605

  O'Connor, J Patrick ^a   Capo, John T ^a   Tan, Virak ^a   Cottrell, Jessica A ^a   Manigrasso, Michaele B ^a   Bontempo, Nicholas ^a   Parsons, J Russell ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENROFLOXACIN; IBUPROFEN; MORPHINE; NEOMYCIN; PLACEBO; POLYMYXIN B; ROFECOXIB; TRIPLE ANTIBIOTIC OINTMENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CALLUS; CARTILAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; FIBULA FRACTURE; FIBULA OSTEOTOMY; FRACTURE HEALING; FRACTURE NONUNION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; MECHANICAL TORSION; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; SURGICAL INFECTION; TORQUE;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMECHANICS; CYCLOOXYGENASE 2 INHIBITORS; FIBULA; FRACTURE HEALING; FRACTURES, BONE; IBUPROFEN; LACTONES; MALE; OSTEOTOMY; RABBITS; SULFONES;

EID: 70450171540     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453670903316769     Document Type: Article

References (24)

1. Allen H L, Wase A, Bear W T. Indomethacin and aspirin: Effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 1980; 51: 595-600.
2. Altman R D, Latta LL, Keer R, Renfree K, Hornicek F J, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing a laboratory study in rats. J Orthop Trauma 1995; 9: 392-400.
3. Baron R, Vigney A, Neff L, Silvergate A, Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. In: Bone histomorphometry: Techniques and interpretation (ed Recker R R). Boca Raton: CRC Press, Inc.; 1983: 13-35.
4. Brideau C, Kargman S, Liu S, Dallob A L, Ehrich E W, Rodger I W, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996; 45: 68-74.
5. Burd T A, Lowry K J, Anglen J O. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg (Am) 2001; 83: 1783-1788
6. Burd T A, Hughes M S, Anglen J O. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg (Br) 2003; 85: 700-705
7. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orth Res 2002; 20: 1164-1169
8. Halpin R A, Geer L A, Zhang K E, Marks T M, Dean D C, Jones A N, et al. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Drug Metab Dispos 2000; 28: 1244-1254
9. Hausman M R, Schaffler M B, Majeska R . Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001; 29: 560-564
10. Keller J, Klamer A, Bak B, Suder P. Effect of local prostaglandin E2 on fracture callus in rabbits. Acta Orthop Scand 1993; 64: 59-63.
11. Maniatopoulos C, Rodriguez A, Deporter D A, Melcher AH. An improved method for preparing histological sections of metallic implants. Int J Oral Maxillofac Implants 1986; 1: 31-37
12. Murnaghan M, Li G, Marsh D R. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: An inhibition of angiogenesis? J Bone Joint Surg (Am) (Suppl 3) 2006; 88: 140-147
13. O'Connor J P, Lysz T. Celecoxib, NSAIDs, and the skeleton. Drugs of Today 2008; 44: 693-709.
14. Paralkar V M, Borovecki F, Ke H Z, Cameron K O, Lefker B, Grasser W A, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A 2003; 100: 6736-6740
15. Paulson S K, Zhang J Y, Breau A P, Hribar J D, Liu N W K, Jessen S M, et al. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Drug Metab Dispos 2000; 28: 514-521
16. Petrack E M, Christopher N C, Kriwinsky J. Pain management in the emergency department: patterns of analgesic utilization. Pediatrics 1997; 99: 711-714
17. Seno H, Oshima M, Ishikawa T O, Oshima H, Takaku K, Chiba T, et al. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 2002; 62: 506-511
18. Simon A M, Manigrasso M B, O'Connor J P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17: 963-976
19. Simon A M, O'Connor J P. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg (Am) 2007; 89: 500-511
20. Steinmeyer J. Pharmacological basis for the therapy of pain and inflammation with non-steroidal anti-inflammatory drugs. Arthritis Research 2000; 2: 379-385
21. Teng X W, Wang S W, Davies N M. Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 796: 225-231
22. Warner T D, Giuliano F, Vojnovic I, Bukasa A, Mitchell J A, Vane J R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A 1999; 96: 7563-7568
23. Williams K M, Knihinicki R D, Day R O. Pharmacokinetics of the enantiomers of ibuprofen in the rabbit. Agents Actions 1991; 34: 381-386
24. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A 2002; 99: 4580-4585